Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab in Retinopathy of Prematurity
NCT00346814Phase 3Recruiting
- Sponsor
- Asociación para Evitar la Ceguera en México
- Start
- Jul 2007
- Primary completion
- Jul 2007
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 3 trial of bevacizumab in retinopathy of prematurity (ROP), sponsored by Asociación para Evitar la Ceguera en México. Primary endpoint: Clinical appearance. Started Jul 2007; status: recruiting.
02
Drugs
bevacizumab
03
Conditions
retinopathy of prematurity (ROP)
Beyond the preview
Go deeper on NCT00346814.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00346814.